Loading...
Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease
OBJECTIVES: Interleukin-23 (IL-23) has emerged as a new therapeutic target for the treatment of inflammatory bowel disease (IBD). As biomarkers of disease state and treatment efficacy are becoming increasingly important in drug development, we sought to identify efficacy biomarkers for anti-IL-23 th...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3365674/ https://ncbi.nlm.nih.gov/pubmed/23238132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ctg.2012.2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|